Congestive Heart Failure
Just Got Easier To Treat.
CHF is a devastating diagnosis for pet owners. Help your clients improve their compliance with once daily dosing. Help your patients, who may be struggling to take their medications, with a highly palatable chewable tablet. CARDALIS™ offers the opportunity to improve compliance AND your patient’s survival6.
Learn more about MMVD and treating with the AVCIM Guidelines.
- Keene et al. 2019. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 33(3):1127-1140.
- Atkins CE, Häggström J. 2012. Pharmacologic Management of Myxomatous Mitral Valve Disease in Dogs. J Vet Cardiol. 14(1):165-184.
- Ovaert P, Elliott J, et al. 2010. Aldosterone receptor antagonists how cardiovascular actions may explain their beneficial effects in heart failure. J Vet Pharmacol Ther. 33(2):109-117.
- Ames MK, Atkins CE. 2016. BEYOND FUROSEMIDE: THE ROLE OF DIURETICS IN CONGESTIVE HEART FAILURE Part 2: Spironolactone. Today’s Veterinary Practice. 6(3), 87-92.
- Ames MK, Atkins CE, Pitt B. 2019. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 33(2):363-382. Review. Erratum in: J Vet Intern Med.33(5):2551.
- Coffman, M, Guillot, E, Blondel, T, et al. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST). J Vet Intern Med. 2021; 1– 15. https://doi.org/10.1111/jvim.16155
CARDALIS and the CARDALIS logo trademarks are the property of Ceva Santé Animale S.A.